My NCBI | Sign In
RSS Settings
  • Search: Bode BW[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 28

    1.

    Defining the importance of daily glycemic control and implications for type 2 diabetes management.

    Bode BW.

    Postgrad Med. 2009 Sep;121(5):82-93. Review.PMID: 19820277 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio.

    Davidson PC, Hebblewhite HR, Steed RD, Bode BW.

    Endocr Pract. 2008 Dec;14(9):1095-101.PMID: 19158048 [PubMed - indexed for MEDLINE]Related articles

    3.

    Self-Monitoring of Blood Glucose (SMBG) in insulin- and non-insulin-using adults with diabetes: consensus recommendations for improving SMBG accuracy, utilization, and research.

    Hirsch IB, Bode BW, Childs BP, Close KL, Fisher WA, Gavin JR, Ginsberg BH, Raine CH, Verderese CA.

    Diabetes Technol Ther. 2008 Dec;10(6):419-39. Review.PMID: 18937550 [PubMed - indexed for MEDLINE]Related articles

    4.

    Continuous glucose monitoring and intensive treatment of type 1 diabetes.

    Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D.

    N Engl J Med. 2008 Oct 2;359(14):1464-76. Epub 2008 Sep 8.PMID: 18779236 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.

    Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA.

    Diabetes Technol Ther. 2008 Oct;10(5):377-83.PMID: 18715214 [PubMed - indexed for MEDLINE]Related articles

    6.

    Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.

    Bode BW.

    Clin Ther. 2007;29 Suppl D:S135-44.PMID: 18191065 [PubMed - indexed for MEDLINE]Related articles

    7.

    Use of a Computerized Intravenous Insulin Algorithm within a Nurse-Directed Protocol for Patients Undergoing Cardiovascular Surgery.

    Davidson PC, Steed RD, Bode BW, Hebblewhite HR, Prevosti L, Cheekati V.

    J Diabetes Sci Technol. 2008 May;2(3):369-75.PMID: 19885200 [PubMed - in process]Free article

    8.

    A Cause-and-Effect-Based Mathematical Curvilinear Model That Predicts the Effects of Self-Monitoring of Blood Glucose Frequency on Hemoglobin A1c and Is Suitable for Statistical Correlations.

    Davidson PC, Bode BW, Steed RD, Hebblewhite HR.

    J Diabetes Sci Technol. 2007 Nov;1(6):850-6.PMID: 19885156 [PubMed - in process]Free article

    9.

    Advances in hemoglobin a1c point of care technology.

    Bode BW, Irvin BR, Pierce JA, Allen M, Clark AL.

    J Diabetes Sci Technol. 2007 May;1(3):405-11.PMID: 19885097 [PubMed - in process]Free article

    10.

    Working to improve care of hospital hyperglycemia through statewide collaboration: the Georgia Hospital Association Diabetes Special Interest Group.

    Cook CB, Stockton L, Baird M, Osburne RC, Davidson PC, Steed RD, Bode BW, Reid J, McGowan KA.

    Endocr Pract. 2007 Jan-Feb;13(1):45-50.PMID: 17360300 [PubMed - indexed for MEDLINE]Related articles

    11.

    Demonstrations and discussions of continuous glucose monitors.

    Bode BW.

    Diabetes Technol Ther. 2005 Oct;7(5):805-8. No abstract available. PMID: 16241888 [PubMed - indexed for MEDLINE]Related articles

    12.

    Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.

    Bode BW, Steed RD, Schleusener DS, Strange P.

    Endocr Pract. 2005 May-Jun;11(3):157-64.PMID: 16239201 [PubMed - indexed for MEDLINE]Related articles

    13.

    Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation.

    Davidson PC, Steed RD, Bode BW.

    Diabetes Care. 2005 Oct;28(10):2418-23.PMID: 16186273 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values.

    Bode BW, Schwartz S, Stubbs HA, Block JE.

    Diabetes Care. 2005 Oct;28(10):2361-6.PMID: 16186263 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial.

    DeFronzo RA, Bergenstal RM, Cefalu WT, Pullman J, Lerman S, Bode BW, Phillips LS; Exubera Phase III Study Group.

    Diabetes Care. 2005 Aug;28(8):1922-8.PMID: 16043733 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

    Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, Santiago OM, Kolaczynski JW; Insulin Aspart CSII/MDI Comparison Study Group.

    Diabetes Care. 2005 Mar;28(3):533-8.PMID: 15735183 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy.

    Bode BW, Braithwaite SS, Steed RD, Davidson PC.

    Endocr Pract. 2004 Mar-Apr;10 Suppl 2:71-80. Review.PMID: 15251644 [PubMed - indexed for MEDLINE]Related articles

    18.

    Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

    Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR.

    Diabetes Care. 2003 Sep;26(9):2598-603.PMID: 12941725 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Intensive insulin therapy and insulin pumps.

    Bode BW.

    Postgrad Med. 2002 Nov;112(5 Suppl Designer):17-21. Review.PMID: 19667601 [PubMed - indexed for MEDLINE]Related articles

    20.

    Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes.

    Bode BW, Tamborlane WV, Davidson PC.

    Postgrad Med. 2002 May;111(5):69-77; quiz 27. Review.PMID: 12040864 [PubMed - indexed for MEDLINE]Related articles

    21.

    Diabetes management in the new millennium using insulin pump therapy.

    Bode BW, Sabbah HT, Gross TM, Fredrickson LP, Davidson PC.

    Diabetes Metab Res Rev. 2002 Jan-Feb;18 Suppl 1:S14-20. Review.PMID: 11921425 [PubMed - indexed for MEDLINE]Related articles

    22.

    Using the continuous glucose monitoring system to improve the management of type 1 diabetes.

    Bode BW, Hirsch IB.

    Diabetes Technol Ther. 2000;2 Suppl 1:S43-8. No abstract available. PMID: 11469631 [PubMed - indexed for MEDLINE]Related articles

    23.

    Clinical utility of the continuous glucose monitoring system.

    Bode BW.

    Diabetes Technol Ther. 2000;2 Suppl 1:S35-41. No abstract available. PMID: 11469630 [PubMed - indexed for MEDLINE]Related articles

    24.

    Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use.

    Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, Mastrototaro JJ.

    Diabetes Technol Ther. 2000 Spring;2(1):49-56.PMID: 11467320 [PubMed - indexed for MEDLINE]Related articles

    25.

    What's ahead in glucose monitoring? New techniques hold promise for improved ease and accuracy.

    Bode BW, Sabbah H, Davidson PC.

    Postgrad Med. 2001 Apr;109(4):41-4, 47-9. Review.PMID: 11317468 [PubMed - indexed for MEDLINE]Related articles

    26.

    Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.

    Bode BW, Strange P.

    Diabetes Care. 2001 Jan;24(1):69-72.PMID: 11194244 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study.

    Bode BW, Gross TM, Thornton KR, Mastrototaro JJ.

    Diabetes Res Clin Pract. 1999 Dec;46(3):183-90. Erratum in: Diabetes Res Clin Pract 2000 Mar;47(3):225. PMID: 10624783 [PubMed - indexed for MEDLINE]Related articles

    28.

    Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes.

    Bode BW, Steed RD, Davidson PC.

    Diabetes Care. 1996 Apr;19(4):324-7.PMID: 8729154 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    3 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity